Lumicell

Newton, MA · Founded 2008 · Privately Held (backing)

Developer of oncology surgical devices designed to improve the way cancer surgery is performed. Lumicell is based in Newton, MA and was founded in 2008. Its last reported valuation was $241 million in Jul 2024. It has raised $333 million across 8 recorded rounds; the latest was a $198 million later-stage round in Apr 2025.

Last reported valuation
$241.0M
Oct 2026
Priced at
—
Total raised
$333.3M
Last round
Later Stage VC
Apr 2025

Lumicell key facts

as of Oct 2026
  • Developer of oncology surgical devices designed to improve the way cancer surgery is performed.
  • Lumicell is valued at approximately $241.0M as of Oct 2026 (last reported valuation).
  • It has raised $333.3M across 8 recorded rounds; the latest was Later Stage VC ($198.1M) in Apr 2025.
  • Notable investors include US National Science Foundation, Kinled Holding, Claridge Venture Partners, BlueIO, Burch Creative Capital — 14 tracked in total.
  • Lumicell has filed 9 Form Ds with the SEC since 2014, most recently May 2025 ($198.1M sold to 64 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$241.0M

Lumicell's last reported valuation, Jul 2024. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Lumicell with a free account
  • ·The complete investor list: 14 names
  • ·Watch Lumicell: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Lumicell funding rounds

8 rounds
Apr 2025Later Stage VC$198.1MSEC filing▮
Jul 2024Seed Round$2.7MSEC filing▮
Feb 2024Seed Round$2.3MSEC filing▮
Jul 2023Later Stage VC$75.8MSEC filing▮
Dec 2018Early Stage VC$20.4MSEC filing▮

Lumicell valuation

Lumicell's last reported valuation was $241 million in Jul 2024. No priced round, secondary trade or fund mark has surfaced since.

How much has Lumicell raised?

Lumicell has raised $333 million across 8 recorded rounds since 2013. The largest was a $75.8 million later-stage round in Jul 2023; the most recent was a $198 million later-stage round in Apr 2025.

Lumicell has filed 9 Form Ds with the SEC since 2014, most recently in May 2025 ($198 million sold to 64 investors).

Lumicell investors

14 investors are on record for Lumicell, including US National Science Foundation, Kinled Holding, Claridge Venture Partners and BlueIO. The later-stage round in Apr 2025 drew 64 investors.

About Lumicell

Developer of oncology surgical devices designed to improve the way cancer surgery is performed. The company's devices use an optical contrast agent that targets the tumor microenvironment to fluoresce near cancer cells at the tumor margin along with a single-cell resolution imaging device to fit into the lumpectomy cavity and scan for residual cancer at the margins, enabling surgeons to remove cancer cells in the cavity walls in real-time during surgery.

Sector
Healthcare
HQ
Newton, MA, United States
Founded
2008
Employees
59
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.